New diabetes clinical trial: Pharmacokinetics and Bioequivalence Study of Empagliflozin+Metformin Hydrochloride 12.5 Mg/1000 Mg Film-coated Tablets (Gedeon Richter Plc., Hungary) Versus Synjardy 12.5 Mg/1000 Mg Film-coated Tablets (Boehringer Ingelheim International GmbH, Germany)
Published on: February 11, 2025 at 11:00PM
Conditions: Diabetes Mellitus Type 2
Interventions: Drug: Empagliflozin + Metformin hydrochloride 12.5 mg/1000 mg combination film-coated tablets; Drug: Synjardy 12.5 mg/1000 mg film-coated tablets
Sponsors: Gedeon Richter Plc.
Not yet recruiting
https://ift.tt/2VzhO0e
Conditions: Diabetes Mellitus Type 2
Interventions: Drug: Empagliflozin + Metformin hydrochloride 12.5 mg/1000 mg combination film-coated tablets; Drug: Synjardy 12.5 mg/1000 mg film-coated tablets
Sponsors: Gedeon Richter Plc.
Not yet recruiting
https://ift.tt/2VzhO0e
Comments
Post a Comment